No Data
No Data
Sichuan Hebang Biotechnology (SHSE:603077) Shareholders Have Lost 21% Over 1 Year, Earnings Decline Likely the Culprit
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if you buy individual stocks, you can do both better or worse than that. Investors i
Hebang Biotech (603077.SH): Methionine project running at full capacity
Gelonghui, May 10, 丨 Hebang Biotech (603077.SH) said on the investor interactive platform that the company's methionine project is running at full capacity, and the company's methionine customers have covered well-known domestic agricultural and animal husbandry enterprises such as Muyuan Co., Ltd., New Hope, Haida Group, Shengnong Co., Ltd.; the company will create more profits for the company through continuous process optimization and sales strategy adjustments.
Hebang Biotech (603077.SH): Has repurchased a total of 114.902 million shares
Gelonghui, May 7, 丨 Hebang Biotech (603077.SH) announced that as of April 30, 2024, the company had repurchased a total of 11,490,200 shares through the Shanghai Stock Exchange system, accounting for 0.13% of the company's total share capital. The highest purchase price was 2.13 yuan/share, the lowest price was 1.98 yuan/share, and the total amount paid was 23,484,329.85 yuan.
Hebang Biotech (603077.SH): It has actually repurchased 2.01% of the company's shares at a cost of 399 million yuan
Gelonghui, April 24, 丨 Hebang Biotech (603077.SH) announced that on April 23, 2024, the company completed this repurchase. It has actually repurchased 177,465,409 shares, accounting for 2.01% of the company's total share capital. The highest repurchase price is 2.46 yuan/share, the lowest repurchase price is 2.06 yuan/share, the average repurchase price is 2.25 yuan/share, and the total capital used is 399 million yuan.
Hebang Biotech (603077.SH) announced its 2023 annual results, with net profit of 1,283 billion yuan, a year-on-year decrease of 66.29%
Hebang Biotech (603077.SH) disclosed its 2023 annual report, and the company achieved 88 revenue in 2023...
Hebang Biotech (603077.SH): A total cost of 286 million yuan to buy back 1.41% of the shares
Gelonghui, April 1, 丨 Hebang Biotech (603077.SH) announced that as of March 31, 2024, the company had repurchased a total of 124,418,767 shares through the Shanghai Stock Exchange system, accounting for 1.41% of the company's total share capital. The highest purchase price was 2.46 yuan/share, the lowest price was 2.27 yuan/share, and the total amount paid was 285,880,508.11 yuan.
No Data